01
Cash & equivalents increased 13.7%
Cash & equivalents changed +13.7% from the comparable as-filed period.
$7.4M→$8.4MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTTranscode Therapeutics, Inc.'s latest supported as-filed period reports net income of -$6.8M, 57.8% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +13.7% from the comparable as-filed period.
Net income changed -57.8% from the comparable as-filed period.
Operating income changed -60.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
RNAZ · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001829635-26-000003SEC ↗4Aug 5, 2026Period Aug 3, 20260001104659-26-091078SEC ↗8-KAug 3, 2026Period Aug 3, 20260001104659-26-089805SEC ↗8-KJul 20, 2026Period Jul 20, 20260001104659-26-085073SEC ↗8-KJul 17, 2026Period Jul 16, 20260001104659-26-084617SEC ↗8-KJul 2, 2026Period Jul 2, 20260001104659-26-080311SEC ↗8-KJun 18, 2026Period Jun 18, 20260001104659-26-075440SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 3, 2026Filed Aug 5, 2026 | DEFJ, LLCReporting owner | ConversionDirect | 11,813,859 | — | — | Form 4 ↗ |
| Aug 3, 2026Filed Aug 5, 2026 | DEFJ, LLCReporting owner | ConversionDirect | 2,020,582 | — | — | Form 4 ↗ |
| Aug 3, 2026Filed Aug 5, 2026 | DEFJ, LLCReporting owner | ConversionDirect | 1,181.39 | $0 | $0 | Form 4 ↗ |
| Aug 3, 2026Filed Aug 5, 2026 | DEFJ, LLCReporting owner | ConversionDirect | 202.06 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed +44.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001104659-26-069810